Jae Sevelius, PhD (Emeritus)

Headshot of Jae Sevelius
User Profile Photo

Jae Sevelius, PhD (Emeritus)

User Profile Name
Director, Center for AIDS Prevention Studies (CAPS)
Professor, School of Medicine
User Profile Title
User Profile Email
Visit CTSI Profile

Biography

Jae Sevelius, PhD, is a licensed clinical psychologist whose research focuses on the investigation of risk and protective factors in transgender and gender diverse communities and relationships between intersectional stigma, gender affirmation, and health-related behaviors and outcomes. Most recently, Dr. Sevelius’ research has focused on developing and testing peer-led interventions to promote sexual health and resilience among transgender people by addressing intersectional stigma among transgender women of color and those affected by HIV.

Dr. Sevelius is Director of the Center for AIDS Prevention Studies (CAPS), Co-Director of the CAPS Developmental Core, and PI and co-founder of the Center of Excellence for Transgender Health.

User Profile Bio

Displaying 51 - 75 of 86

  1. Gamarel KE, Sevelius JM, Reisner SL, Richardson RL, Darbes LA, Nemoto T, Operario D. Relationship Stigma and HIV Risk Behavior Among Cisgender Men Partnered with Transgender Women: The Moderating Role of Sexual Identity. Arch Sex Behav. 2020 01; 49(1):175-184.
    http://www.ncbi.nlm.nih.gov/pubmed/31086428
  2. Cahill SR, Keatley J, Wade Taylor S, Sevelius J, Elsesser SA, Geffen SR, Wang T, Mayer KH. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco. AIDS Care. 2020 05; 32(5):585-593.
    http://www.ncbi.nlm.nih.gov/pubmed/29143629
  3. Kendig NE, Cubitt A, Moss A, Sevelius J. Developing Correctional Policy, Practice, and Clinical Care Considerations for Incarcerated Transgender Patients Through Collaborative Stakeholder Engagement. J Correct Health Care. 2019 07; 25(3):277-286.
    http://www.ncbi.nlm.nih.gov/pubmed/28299969
  4. Meerwijk EL, Sevelius JM. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 02; 107(2):e1-e8.
    http://www.ncbi.nlm.nih.gov/pubmed/28075632
  5. George, J.R., Michaels, T.I., Sevelius, J.M., Williams, M. . The Psychedelic Renaissance and the limitations of a White-dominant medical framework. Journal of Psychedelic Studies. 2019.
    http://www.ncbi.nlm.nih.gov/pubmed/28075643
  6. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group. The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 2017.
  7. Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105.
    http://www.ncbi.nlm.nih.gov/pubmed/27760683
  8. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. . 2016 08 15; 72 Suppl 3:S226-9.
    http://www.ncbi.nlm.nih.gov/pubmed/27429187
  9. Sevelius J, Murray LR, Martinez Fernandes N, Veras MA, Grinsztejn B, Lippman SA. Optimising HIV programming for transgender women in Brazil. Cult Health Sex. 2019 05; 21(5):543-558.
    http://www.ncbi.nlm.nih.gov/pubmed/27431475
  10. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 05; 3(5):e200-1.
    http://www.ncbi.nlm.nih.gov/pubmed/27126486
  11. Hoffkling A, Obedin-Maliver J, Sevelius J. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers. BMC Pregnancy Childbirth. 2017 Nov 08; 17(Suppl 2):332.
    http://www.ncbi.nlm.nih.gov/pubmed/27080150
  12. Lippman SA, Neilands TB, Leslie HH, Maman S, MacPhail C, Twine R, Peacock D, Kahn K, Pettifor A. Development, validation, and performance of a scale to measure community mobilization. Soc Sci Med. 2016 05; 157:127-37.
    http://www.ncbi.nlm.nih.gov/pubmed/26511864
  13. Meerwijk EL, Sevelius JM. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 Feb; 107(2):216.
    http://www.ncbi.nlm.nih.gov/pubmed/26835800
  14. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group. The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 2017.
    http://www.ncbi.nlm.nih.gov/pubmed/26910276
  15. Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105.
    http://www.ncbi.nlm.nih.gov/pubmed/26963756
  16. Kaplan RL, Khoury CE, Field ERS, Mokhbat J. Living Day by Day: The Meaning of Living With HIV/AIDS Among Women in Lebanon. Glob Qual Nurs Res. 2016 Jan-Dec; 3:2333393616650082.
    http://www.ncbi.nlm.nih.gov/pubmed/26824592
  17. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM, iPrEx investigators . HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 Dec; 2(12):e512-9.
    http://www.ncbi.nlm.nih.gov/pubmed/26614965
  18. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 05; 3(5):e200-1.
    http://www.ncbi.nlm.nih.gov/pubmed/26384946
  19. Pollock L, Silva-Santisteban A, Sevelius J, Salazar X. 'You should build yourself up as a whole product': Transgender female identity in Lima, Peru. Glob Public Health. 2016 Aug-Sep; 11(7-8):981-93.
    http://www.ncbi.nlm.nih.gov/pubmed/25415163
  20. Sevelius, J. . Transgender Issues in HIV. HIV Specialist: Patient Care, Practice Management, and Professional Information for HIV Care Providers. American Academy of HIV Medicine. 2014.
  21. Sevelius, J., Sa’id, A., Warri, V.. Becoming Janet Mock. [Review of the book Redefining realness: My path to womanhood, identity, love and so much more., by J. Mock]. PsychCRITIQUES. 2014; 51(59).
  22. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016 Apr; 20(4):928-38.
    http://www.ncbi.nlm.nih.gov/pubmed/24880490
  23. Bockting W, Coleman E, Deutsch MB, Guillamon A, Meyer I, Meyer W, Reisner S, Sevelius J, Ettner R. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):188-97.
    http://www.ncbi.nlm.nih.gov/pubmed/24646419
  24. Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):168-71.
    http://www.ncbi.nlm.nih.gov/pubmed/24317955
  25. Sevelius JM, Keatley J, Calma N, Arnold E. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016 Aug-Sep; 11(7-8):1060-75.
    http://www.ncbi.nlm.nih.gov/pubmed/25190135